Synthetic Cannabinoid-Associated Coagulopathy. 2019

Amar H Kelkar, and Michael D Tarantino, and Jonathan C Roberts
University of Florida Shands Hospital, Gainesville, FL amar.kelkar@medicine.ufl.edu.

UI MeSH Term Description Entries
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D002186 Cannabinoids Compounds having the cannabinoid structure. They were originally extracted from Cannabis sativa L. The most pharmacologically active constituents are TETRAHYDROCANNABINOL; CANNABINOL; and CANNABIDIOL. Cannabinoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Amar H Kelkar, and Michael D Tarantino, and Jonathan C Roberts
January 2019, The New England journal of medicine,
Amar H Kelkar, and Michael D Tarantino, and Jonathan C Roberts
January 2019, The New England journal of medicine,
Amar H Kelkar, and Michael D Tarantino, and Jonathan C Roberts
February 2019, Blood,
Amar H Kelkar, and Michael D Tarantino, and Jonathan C Roberts
January 2019, Psychosomatics,
Amar H Kelkar, and Michael D Tarantino, and Jonathan C Roberts
March 2023, Cureus,
Amar H Kelkar, and Michael D Tarantino, and Jonathan C Roberts
November 2018, Transfusion,
Amar H Kelkar, and Michael D Tarantino, and Jonathan C Roberts
October 2019, Annals of internal medicine,
Amar H Kelkar, and Michael D Tarantino, and Jonathan C Roberts
June 2024, Trauma case reports,
Amar H Kelkar, and Michael D Tarantino, and Jonathan C Roberts
March 2013, Clinical toxicology (Philadelphia, Pa.),
Copied contents to your clipboard!